Much like RBQM, decentralized clinical trials (DCTs) are an approach to conducting clinical trials, interacting with patients and sites, and implementing fit for purpose technologies for the collection and capture of critical data and monitoring patient safety. The overall objective of DCTs is the facilitation is to lessen the patient burden of patients and sites, therefore increasing patient participation, while ensuring the collection and capture of critical data, such as efficacy endpoints and safety data.
In the fourth episode of the RBQM podcast series, Amy Adams, Senior Director, Clinical Operations and Cris McDavid, Director, Clinical Operations discuss some questions to ask when developing a risk-based framework for decentralized clinical trials.
Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 3
Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 2
Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1
CAR-T boxed warnings: What comes next?
Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements
Three trends impacting market access in the EU
How can we advance fair and ethical reimbursement for patients?
Beyond the Binary: Navigating Gender Diversity in Clinical Research
Why Rare Disease Therapeutics Need Early Market Access Planning
CROs and Their Role for Nano-rare
Careers at Parexel — FSP Podcast Series | Episode 2: Celebrating a 25-Year Career with Kerri McCaul-Claus
Careers at Parexel — FSP Podcast Series | Episode 1: Get Recruited to Be a Clinical Research Associate: The Benefits of Parexel’s FSP Program
The Parexel Podcast | Episode 20: Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Decentrally Speaking | Episode 3: Integrating the Patient Voice into Decentralized Trials
RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
RBQM Podcast Series | Episode 2: Cultivating Risk-based Behaviors
Decentrally Speaking, a Parexel Podcast | Episode 1: Optimizing Trial Inclusivity For Patients From Under-Represented Communities
Episode 19: Improving Rare Disease Drug Development
Create your
podcast in
minutes
It is Free
Short Wave
Unexplainable
Speaking of Psychology
Stuff To Blow Your Mind
The Science of Life with Dr. Raven Baxter